Stay updated on Nivolumab Ipilimumab RT for Sarcoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Ipilimumab RT for Sarcoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Ipilimumab RT for Sarcoma Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The page has updated the study dates for a Phase II clinical trial involving Nivolumab and Ipilimumab, moving from October 2024 to April 2025, indicating a significant shift in the timeline for this research.
    Difference
    1%
    Check dated 2025-05-01T04:44:41.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The page has been updated to include new identifiers and collaborators related to a clinical trial for dedifferentiated liposarcoma and undifferentiated pleomorphic sarcoma, while significant details about the trial's objectives and treatment protocols have been removed.
    Difference
    52%
    Check dated 2025-04-16T14:35:05.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-09T09:24:00.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.1%
    Check dated 2025-04-01T23:27:56.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    0.9%
    Check dated 2025-02-24T21:16:07.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    The webpage now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    0.9%
    Check dated 2025-02-10T10:09:49.000Z thumbnail image

Stay in the know with updates to Nivolumab Ipilimumab RT for Sarcoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Ipilimumab RT for Sarcoma Clinical Trial page.